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Cellular  immune  responses have been shown to play an  important  role in 
determining  the outcome of virus infection in several experimental  models (1, 
2).  Among  the  manifestations  of  cellular  immunity  in  viral  infection  the 
capacity of specifically sensitized thymus-derived  (T)  1 lymphocytes to destroy 
virus-infected  target  cells  in  vitro  has  been  demonstrated  to  correlate  with 
elimination of infectious virus in vivo (3, 4) and hence suggests a direct role for 
cytotoxic  T  lymphocytes  (CTL)  in  recovery  from  virus  infection.  Since  the 
functional  activity  of  CTL  raised  against  viruses  (5-8)  as  well  as  minor 
histocompatibility antigens  (9,  10) and chemically modified cells  (11) has also 
been shown to be under  the  control  of genes in the major histocompatibility 
complex (MHC), the specificity of CTL for both the gene products of the MHC 
and the foreign determinant on target cell surfaces has been analyzed in great 
detail.  On the other hand,  much less information is presently available on the 
requirements  for induction  of virus-specific CTL.  An issue which is presently 
controversial is the requirement  for infectious virus in the induction of virus- 
specific CTL. Several laboratories have reported that CTL responses to a diverse 
group of viruses can be readily stimulated with inactivated virion preparations 
(12-15), whereas infectious virus is required for CTL induction in other hands 
(16).  Also inactivated virus  (12,  13) or indeed virion subunit preparations  (17) 
have  been  reported  to  sensitize  target  cells  for  CTL-mediated  lysis  in  the 
absence of nascent viral protein in the target  cell  (12,  17), whereas infectious 
virus and nascent viral protein synthesis is required for lysis of target cells in 
other  circumstances  (18). The  resolution  of this  issue  would  appear  to  have 
direct implications with respect to viral vaccines, particularly in assessing the 
efficacy of live virus and killed virus vaccines. Furthermore,  an understanding 
of the  role  of viral  infectivity both  in  the  induction  of CTL  and  target  cell 
sensitization may be of value in understanding the mechanism of CTL recogni- 
tion. 
This  report  examines  the  capacity  of infectious  and  inactivated  influenza 
virus to stimulate virus-specific CTL responses in vivo and in vitro.  We have 
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i  Abbreviations used in this paper:  CTL, cytotoxic  thymus-derived lymphocyte(s); EIDso, egg 
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observed  that  while  infectious  influenza  virus  was  capable  of stimulating  both 
CTL responses  and humoral  immune  responses  in vivo over a  broad  immunizing 
dose  range,  ultra-violet  inactivated  influenza  virus  neither  induced  CTL  re- 
sponses  in vivo nor sensitized  putative  target  cells for lysis by influenza-specific 
CTL in spite of its capacity  to stimulate  a  comparable  in vivo humoral  immune 
response.  Inactivated  influenza  virus could, however,  stimulate  a  CTL  response 
in  vitro.  These  results  are  discussed  in  the  light  of the  observations  outlined 
above.  Possible  implications  for  virus-specific  CTL  induction  are  also  consid- 
ered. 
Materials  and  Methods 
General.  Male  BALB/C  mice  (7-12  wk  of age) bred  at the John  Curtin  School were  used 
throughout.  P815 mastocytoma cells, maintained in tissue culture, were used as target cells in all 
experiments (19). Eagle's minimal essential medium (Grand Island Biological Co., Grand Island, 
N.Y.  catalogue no.  F-15),  supplemented  with  10% heat-inactivated fetal calf serum  (Common- 
wealth Serum Laboratories,  Melbourne, Australia) was used as the medium in all cytotoxicity 
assay. 
Viruses.  Influenza  virus  strains  A/WSN  (H0/N1),  A/JAP/305  (H2/N2),  and  B/LEE  were 
grown in  the allantoic cavity of embryonated  eggs and  stored  as  infectious allantoic fluid as 
described previously (19). 
Virus Purification and Inactivation.  Before inactivation, virus, as infectious allantoic fluid, 
was  concentrated  and  purified  according  to  standard  procedures  (20). Influenza  A]WSN  was 
concentrated  by  adsorption-elution  from  fowl  erythrocytes  followed  by  ultracentrifugation. 
Influenza A/JAP was similarly concentrated and further purified by velocity centrifugation over 
sucrose gradients (20). Purified virus was diluted to a concentration of 105 hemagglutination units 
(HAU)/ml in sterile phosphate-buffered  saline  (PBS) and exposed to a 25-watt ultraviolet (UV) 
light source at a distance of 20 cm for 7 min in 9 cm glass Petri dishes containing 5-6 ml of virus 
suspension.  The virus suspension was stirred constantly during exposure to the UV source. The 
infectious viruses had a titer of 5 × 108 -109 EIDso U/ml and 1.5-3.0 x  10  a HAU/ml. Egg infectivity 
titers were determined by the modified Spearman-K/iber method  (21). Hemagglutination titra- 
tions were performed according to Fazekas de St. Groth and Webster (22). No residual infectious 
virus was detectable in inactivated virus preparations as measured by egg infectivity. No loss of 
viral  hemagglutinating  activity was  observed  after  virus  inactivation.  Inactivated  virus  was 
stored at 4°C. 
Immunization.  Mice were inoculated with virus by the intravenous route. Infectious virus, as 
allantoic fluid was diluted in PBS and administered in quantities as indicated in the text. UV- 
inactivated virus was administered in a similar fashion. For in vivo primary cytotoxic responses, 
spleens  from  three  donor  mice  were  removed  6  days  after  immunization  and  a  spleen  cell 
suspension  was  prepared  as  previously  described  (8). For  in  vivo secondary  responses,  mice 
primed previously with 100 HAU of infectious virus were inoculated 3-4 wk later with infectious 
or inactivated virus as indicated in the text. 5 days later spleens from three donors were removed 
and processed as above. For adoptive in vivo secondary responses 80-100  ×  l0  s spleen cells from 
donors primed 3-4 wk previously with infectious virus were transferred intravenously into age 
and  sex matched recipient mice which had received 450 rads of total body v-irradiation from a 
radioactive  cobalt  source.  Recipient  mice  were  inoculated  with  virus  immediately  after  cell 
transfer.  Recipient spleens were removed 5 days later and tested for cytotoxicity. 
In Vitro Secondary Responses.  Cytotoxic T lymphocytes were generated in vitro essentially as 
described previously (8,  19). Briefly, 40  x  106 spleen cells from mice primed 3-8 wk previously 
with 100 HAU of infectious influenza virus were cultured with "stimulator" cells in 25 cm  2 Falcon 
tissue culture flasks (Becton, Dickinson and Co., Oxnard, Calif.) containing 15 ml of medium (8, 
19).  The responder  cell to  stimulator  cell ratio was  10:1. Stimulator cells consisted  of normal 
syngeneic spleen cells either infected with 5 EIDso  U  of infectious virus per nucleated cell (60 
HAU of infectious  virus  per  4  ×  l0  s  cells)  or  treated  with  various  quantities  of inactivated 
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responder cells to remove unadsorbed virus. Viable cells were tested for cytotoxic activity after 5 
days of culture. Recovery of viable cells was 20-40% at that time. 
Assay for Cell-Mediated Cytotoxicity.  The 51Cr release cytotoxicity assay was carried out as 
described in previous reports  (8,  19).  51Cr-labeled P815 target cells were infected in suspension 
with 10 EIDs0 U  of infectious virus per cell  (30  HAU of infectious virus per 105 target cells) as 
described (19). Target cells were treated with various quantities of UV-inactivated influenza virus 
in  an identical fashion.  Unless otherwise  indicated in  the text,  assay times  were  8-8.5  h  for 
primary effector activity and 6.5 h  for secondary effectors.  Spontaneous ~Cr release from target 
cells incubated with medium only usually ranged'from 5 to 15% and was always less than 18%. 
Percent specific slCr release was obtained from the formula: 
test  counts - spontaneous release  × 100. 
water lysis  counts - spontaneous release 
All values represent the mean percent specific  5~Cr release of  four replicate wells. 
Assay for Anti-Hemagglutinin Antibody.  Serum  anti-hemagglutinin  antibody was quanti- 
tated by the microtitration hemagglutination inhibition test (23).  4 HAU  of  virus in a vol 0.025 ml 
were added to serial  twofold dilutions of  serum in a final vol of  0.025 ml of  PBS. After 35 rain of 
incubation, 0.025 ml of  a 1% suspension of  fowl erythrocytes  was added to each well. After 30 rain 
of incubation,  the hemagglutination-inhibition  endpoint was determined. All sera were treated 
with Vibrio  cholera  receptor-destroying  enzyme  (Center for Disease Control, Atlanta,Ga.) and 
heated to 56°C for 30 rain  to remove nonspecific inhibitors. Preimmune  sera from immune  sera 
donors served as controls. 
Results 
In a  series of preliminary experiments the capacity of influenza virus strain 
A/WSN to induce CTL was assessed after inactivation of the virus by several 
different methods. In contrast to results obtained with infectious influenza virus 
(8, 19) no influenza-specific CTL activity was detectable in the spleens of mice 
after intravenous inoculation of A/WSN virus inactivated either by UV irradia- 
tion,  sodium  deoxycholate  disruption,  or  heat  treatment  (data  not  shown). 
Because UV irradiation  was considered to have the least detrimental  effect on 
both  virion  architecture  and  viral  antigen  stability,  this  method  of virus 
inactivation was used in subsequent experiments. 
Antigen Dose Dependence of the in Vivo Primary CTL Response to Infectious 
Influenza Virus.  Fig. 1 shows the cytotoxic response from the spleens of mice 
6  days after  administration  of the  indicated  doses of infectious  influenza  A/ 
WSN.  Cytotoxic activity was detectable with infectious virus doses as low as 
10  -3 HAU (102 EIDso U).  The magnitude  of lytic activity was directly propor- 
tional to the concentration of infectious virus in the immunizing inoculum over 
a  range  of antigen  doses.  This  direct relationship  between immunizing  virus 
dose and splenic CTL activity was consistently observed in a  series of experi- 
ments.  An  analysis  of  the  kinetics  of the  cytotoxic  response  (not  shown) 
indicated that as demonstrated previously (8, 19, 24) optimal cytotoxic activity 
was maximum at 5-7 days postinoculation.  Thus, the difference in magnitude 
of the  cytotoxic response  with  different  virus  doses  was  not  attributable  to 
differences in the kinetics of appearance of cytotoxic activity. The T-cell origin 
of the cytotoxic cell activity has been demonstrated previously (8, 19). 
Absence of an in Vivo Primary CTL Response with UV-Inactivated Influenza 
Virus.  Table  I  shows  a  comparison  CTL  response  of mice  6  days after  i.v. 
inoculation  with various concentrations  of infectious or UV-inactivated influ- 
enza A/WSN. In contrast to infectious virus, UV-inactivated A/WSN virus did T.  J.  BRACIALE  AND  K.  L.  YAP  1239 
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FIG.  i.  Antigen dose dependence of the in vivo primary cytotoxic T-cell response to 
infectious influenza virus A/WSN.  Spleen cells  from pools of  three mice were obtained 6 
days after  primary immunization with the indicated virus dose (abscissa)  and tested for 
cytotoxicity  on  51Cr-labeled  A/WSN  infected  target cells  (©  O). The cytotoxic  activity  of 
normal spleen cells  is also included (D).  The effector  cell:  target cell  ratio  is 50:1.  Values 
are the mean of  four individual wells. Standard errors less  than _+ 3% in all cases have 
been omitted. 
not generate a significant CTL response in vivo with virus doses as high as 104 
HAU. The low level of cytotoxicity observed in the assay at the highest effector 
to target  ratio  is comparable  to the  background cytotoxicity observable with 
normal  spleen  cells and  probably does not reflect low level specific cytotoxic 
activity. Spleens from mice immunized with l0 s HAU of inactivated virus were 
also examined for CTL activity at 2-day intervals up to 10 days after immuni- 
zation.  No cytotoxic activity was detectable during this period at a  time when 
optimal CTL responses are detectable in a variety of diverse viral systems (25). 
Although these results were obtained with influenza  strain  A/WSN,  we have 
obtained  similar  results  with two other influenza strains:  A/JAP/305  (H2N2) 
and B/LEE. 
Humoral  Immune  Response  to  Infectious  and  Inactivated  Influenza 
Virus.  Since the above results indicated a marked disparity between infectious 
and UV-inactivated virus in their respective capacities to induce CTL responses 
in vivo, the humoral  immune response to various doses of these virus prepar- 
tions  was  examined  (Table  II).  Both  virus  preparations  induced  significant 
levels  of  anti-viral  antibody  as  measured  by  hemagglutination  inhibition. 
Likewise  for  both  virus  preparations  the  magnitude  of  the  response  was 
proportional to the immunizing  antigen  dose. Although the humoral response 
to  infectious virus was greater  at  lower immunizing  doses,  similar  antibody 
levels were achieved upon immunization  with higher doses of UV-inactivated 
virus, i.e.,  102-104 HAU. 
Absence of an  in Vivo Secondary CTL Response on Challenge  with Inacti- 
vated Influenza Virus.  Secondary CTL responses to infectious influenza virus 
have  been  demonstrated  both in  vivo  (24)  and  in  vitro  (8,  19)  after primary 
immunization with infectious influenza virus. Since the above results indicated 
that UV-inactivated influenza was a poor stimulator of a primary CTL response, 1240  INDUCTION  OF  VIRUS-SPECIFIC  CYTOTOXIC  T  CELLS 
TABLE  I 
Comparison of the in Vivo Primary Cell-Mediated Cytotoxic 
Response to Infectious and Inactivated Influenza Virus* 
Virus dose* 
Effector cell 
to target  cell 
ratio§ 
%  Specific  siCr release on A/WSN  in- 
fected P815 target cells¶ 
Immunization~l 
Infectious virus  Inactivated  virus 
10  -2  25:1  19.5  --+ 0.4**  NT*$ 
50:1  43.4  ±  1.9  " 
100:1  48.4  ±  2.7  " 
10-'  25:1  43.3  -+  1.5  0.1 
50:1  59.5  ±  0.5  1.0  ±  0.1 
100:1  57.5  -+  2.9  3.1  _+  0.1 
100  25:1  47.0  -+  1.8  0.6 
50:1  62.5  ±  1.2  2.0  ±  0.1 
100:1  74.6  ±  0.6  3.8  ±  0.1 
10  ~  25:1  60.1  -+  1.2  0.7 
50:1  69.5  ±  2.5  2.7  ±  0.1 
100:1  79.3  -+  4.6  6.3  ±  0.2 
10  2  25:1  64.0  -+  1.1  1.7  _+  0.1 
50:1  73.8  ±  1,2  3,6  _+  0.3 
100:1  81.7  ±  1.9  7.3  ±  0.3 
10  3  25:1  NT  1.5  ±  0.1 
50:1  "  2.9  ±  0.1 
100:1  "  5.2  ±  0.3 
104  25:1  NT  3.0  ±  0.1 
50:1  "  6.0  -+  0.2 
100:1  "  8.5  ±  0.2 
* BALB/c  mice were immunized  i.v.  with the indicated dose of  infec- 
tious or UV-inactivated influenza AJWSN.  6 days later  spleen cells 
from pools of  three mice were assayed for cytotoxicity. 
* Virus dose employed in primary immunization measured in HAU.  i 
HAU  of  infectious virus contains 1.7-3.0 × 105 EIDso U  of  infectious 
virus. 
§ 2 ×  I0  ~  s'Cr-labeled P815 cells/well. 
¶ All effector populations  were simultaneously  examined  on target 
cells infected with A/WSN  and B/LEE  viruses. 5'Cr release values 
on B/LEE  infected targets were <10%  and <2%  for cells  obtained 
from donors receiving infectious and inactivated virus respectively. 
II Indicates source of  spleen cells,  i.e.  from donors receiving infectious 
or inactivated  virus. 
**  Means  ±  standard  errors  of the  mean  from  four wells with  sponta- 
neous  release  subtracted. 
*~  Not tested. T.  J.  BRACIALE AND  K.  L.  YAP 
TABLE II 
Primary Serum Anti-Hemagglutinin Antibody Response  to 
Infectious  and Inactivated Influenza Virus* 
Virus dose* 
Anti-hemagglutinin  antibody titer§ 
Immunizationll 
Infectious virus  Inactivated virus 
i04  NT  160  _+  0¶ 
I03  160  _+  0  NT 
102  160  _+  0  80  +_ 0 
I0'  113  _+  11  NT 
10  °  95_+  10  16-+ 11 
10-'  73 -+ II  NT 
10  -2  20 -+ 11  <10 
* Groups of four mice were immunized i.v. with the indicated doze of 
infectious  or UV-inactivated  influenza A/WSN. 10 days later, individ- 
ual mice were bled from  the tail vein and the serum hemagglutination 
inhibiting antibody titer determined. 
* As in Table I. 
§ Hemagglutination inhibiting antibody titer as measured in the micro- 
titration hemagglutination-inhibition  test. 
II Indicates source of serum, i.e. from mice receiving infectious or 
inactivated virus. 
¶ Values are the reciprocals of  means _+_+  standard errors of  the highest 
serum dilution giving complete inhibition of hemagglutination  from 
four individual mice. 
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it was of interest to examine the capacity of inactivated virus to induce a  CTL 
response  in  mice  previously  primed  with  infectious  influenza  virus.  Mice 
immunized 3-4 wk previously with 100 HAU of infectious influenza A/WSN or 
A/JAP were challenged with 1,000  HAU of UV-inactivated A/WSN or A/JAP 
virus.  Control mice received no further treatment beyond primary immuniza- 
tion. After 5 days the cytotoxic activity of spleen ceils from the various groups 
was examined on target cells infected with A/WSN,  A/JAP,  B/LEE, or unin- 
fected target cells (Table III). In no instance did the cytotoxic activity of spleen 
cells from mice receiving secondary challenge with inactivated influenza virus 
exceed the  background cytotoxicity of cells from control mice.  On  the other 
hand,  spleen cells from mice previously primed with infectious A/WSN virus 
showed significant cytotoxic activity on both A/WSN and A/JAP infected target 
cells when secondarily stimulated with infectious A/JAP virus (Table III). 
Generation  of an  in  Vitro  Secondary  Response  to  Inactivated  Influenza 
Virus.  Although the above results would indicate that inactivated influenza 
is  also an  inefficient stimulator of secondary CTL responses,  the presence of 
circulating anti-viral antibody in the primed recipients could alter the second- 
ary CTL response upon challenge with inactivated virus.  Indeed, it has been 
demonstrated  that  poor  secondary CTL  responses  are  observed  when  mice, 
previously primed with a given infectious type A influenza strain are challenged 
with the homologous infectious virus (24), whereas secondary stimulation with 
an infectious type A influenza strain of a different subtype generates good CTL 
responses in the primed recipients (Table III and [24]). This poor cytotoxic T-cell 
response on secondary stimulation with homologous virus appears to be due to 1242  INDUCTION  OF  VIRUS-SPECIFIC  CYTOTOXIC  T  CELLS 
TABLE  III 
In Vivo Secondary Cell-Mediated Cytotoxic  Response to Inactivated Influenza Virus 
Immunization*  % Specific 51Cr release from target cells$ 
Primary  Secondary  Uninfected  A/WSN  A/JAP  B/LEE 
A/WSN  A/WSN  2.5  _+  0.1  13.5  -+  0.7  9.3  -+ 0.3  0 
(Inactivated) 
A/WSN  A/JAP  2.4  _+  0.1  18.4  _+  0.9  12.0  -+  1.0  2.5  _+  0,2 
(Inactivated) 
A/WSN  None  0  17.3  ±  0.8  14.7  -+  0.4  0.7 
A/JAP  A/WSN  3.9  _+  0.2  9.8  -+  0.3  11.5  _+  0.5  0.8 
(Inactivated) 
A/JAP  A/JAP  0  7.6  -+  0.1  13.3  -+  0.3  0.3 
(Inactivated) 
A/JAP  None  0  12.5  -+ 0.6  10.3  -+ 0.4  0.7 
A/WSN  A/JAP  0  60.4  ±  1.4  54.3  _+  1.5  0.3 
(Infectious) 
* 3-4 wk after  primary immunization  with infectious  A/WSN or A/JAP virus  mice  were 
challenged  with  either  inactivated  A/WSN or  A/JAP virus  as indicated  in the  text.  Controls 
consisted  of  mice  receiving  no secondary  immunization  and AJWSN primed  mice  challenged 
with  100  HAU of  infectious  A/JAP  virus.  5  days  later,  spleen  cells  from  pools  of  three  mice  were 
assayed  for  cytotoxic  activity  on the  indicated  target  cells.  Effector  cell:target  cell  ratios  were 
100:1. 
Values  are  the  means -+  standard  errors  of  the  mean from  four  wells  with  spontaneous  release 
subtracted. 
neutralization of  the infectious  virus inoculum by circulating antibody in the 
primed recipient.  Since highly potent secondary CTL responses to homologous 
type A  influenza virus can be obtained by in vitro  secondary stimulation of 
primed cells  (8, 19),  we examined the capacity of  inactivated virus to stimulate 
a secondary CTL response in vitro  where the problem of  circulating anti-viral 
antibody could be circumvented. Spleen cells  from mice previously immunized 
with infectious  A/JAP virus were cultured with normal spleen cell  stimulators 
which had been treated with either inactivated A/JAP virus, inactivated A/ 
WSN  virus, or infectious  A/JAP, A/WSN,  or B/LEE viruses.  After 5 days the 
cytotoxic  activity  of  the cultured cells  was examined (Table IV). In contrast to 
the results obtained above, spleen cells  from A/JAP-primed  mice generated 
potent cytotoxic  effector  cells  when stimulated in vitro  with UV-inactivated A/ 
JAP virus. Furthermore, the magnitude of  the response was dependent upon 
the dose of stimulating antigen. Also no response was observed when normal 
spleen cells,  treated with inactivated A/WSN  virus, were used for in vitro 
stimulation. It is of  interest  to note the cytotoxic  activity  generated by A/JAP 
primed cells  after  stimulation with inactivated A/JAP was directed exclusively 
to A/JAP-infected target cells.  There was no lysis  of  A/WSN  infected targets 
above the background seen with uninfected target cells  or target cells  infected 
with the serologically  unrelated B/LEE influenza virus. This observation is in 
contrast to the finding with infectious virus where, as has been previously 
shown  (19),  stimulation  of A/JAP primed cells  with stimulator cells  treated 
(infected) with infectious  A/JAP or A/WSN  virus generates CTL  which can 
efficiently  lyse  both A/WSN  and A/JAP infected  targets.  Finally, there was no T.  J.  BRACIALE  AND  K.  L.  YAP  1243 
TABLE  IV 
In Vitro Secondary  Cell-Mediated  Cytotoxic Response  to Inactivated  Influenza Virus 
Effector cell 
In vitro stimula- 
to target cell 
tion* 
ratio§ 
% Specific 5~Cr release from target cells$ 
Uninfected  AJWSN  A/JAP  B/LEE 
A/JAP-Inactivated  1:1  0.4  1.3  _+  0.1  3.4 ±  0.3  0 
(25 HAU)II  2.5:1  0.5  1.8 ±  0.1  9.8  ±  0.3  1.6  ±  0.1 
5:1  2.2  ±  0.1  3.3  ±  0.1  18.3  ±  0.5  4.3  ±  0.2 
A/JAP-Inactivated  i:I  0  I.I  ±  0.1  18,8 +_  0.1  I.i  ±  0.I 
(250 HAU)  2.5:1  1.4 _+  0.1  3.5  ±  0.2  43.0  _+  1.3  2.4 ±  0.1 
5:1  3.2  _+ 0.1  5.8 ±  0.2  61.9  ±  1.3  4.8  ±  0.2 
A/JAP-Inactivated  1:1  2.0  +  0.1  3.4 _+ 0.1  41.5  ±  1.5  2.2  _+ 0.1 
(2,500  HAU)  2.5:1  5.4 ±  0.2  8.8 ±  0.4  66.5  _+  1.7  6.9 ±  0.2 
5:1  10.5  _+ 0.2  15.2  ±  0.3  79.7  _+  1.5  14.3  ±  0.4 
A/WSN-Inactivated  1:1  0  0  1.3  ±  0.1  1.0 
(2,500  HAU)  2.5:1  2.2  ±  0.1  2.6  _+ 0.1  3.1  ±  0.1  2.3  ±  0.1 
5:1  4.1  _+ 0.2  5,2  ±  0.1  4.3  _+  0.1  4.5  ±  0.2 
A/JAP-Infectious 
A/WSN-Infectious 
B/LEE-Infectious 
-¶ 
1:1  4.5  ±  0.2  42.6  ±  1.2  60.2  _+  1.5  4.8 ±  0.1 
2.5:1  10,3  ±  0.5  58.2  _+  1.2  73.2  ±  2.7  9.7  ±  0.3 
5:1  16.5  ±  0.4  66.2  ±  2.1  78.6  ±  2.4  18.7  _+  0.2 
1:1  1.7  ±  0.1  30.5 ±  1.1  34.3  ±  1.9  1.5 +_ 0.1 
2.5:1  4.1  ±  0.3  55.4 ±  1.8  59.8 ±  1.3  3.4 ±  0.1 
5:1  8.0 ±  0.6  62.0  ±  1.0  80.2  _+  0.6  7.2  ±  0.2 
1:1  2,1  ±  0.1  3.2  ±  0,1  2.6  _+  0.1  2.3  ±  0,1 
2.5:1  4.6 ±  0.3  4.9  ±  0.1  4.5 ±  0.3  5.2 -+ 0.1 
5:1  6.9  ±  0.3  7.3  ±  0.1  7.7 ±  0.3  7.3  ±  0.4 
1:1  3.4 _+  0.2  2.0  ±  0.1  0.7  1.7  ±  0,1 
2.5:1  4.5  ±  0.3  2.3  -+ 0.1  1,7  ±  0.1  2.1  ±  0.1 
5:1  4.2  ±  0.2  3.9 ±  0.1  3.6  ±  0.1  2.9 _+ 0.2 
* Spleen  cells from A/JAP-immune mice were  cultured in  vitro  with  stimulator spleen cells 
treated with infectious or  inactivated influenza virus as described  (Materials and Methods). 
After 5 days of culture, the cytotoxic activity of the responder cells was examined. 
$ As in Table III. 
§ As in Table I. 
II Parentheses indicate dose of inactivated virus incubated with stimulator spleen cells. 
¶  Indicates normal stimulator spleen cells not exposed to virus. 
cytotoxic  activity  detectable  in cultures  stimulated  with  untreated  or influenza 
B/LEE  infected  stimulators. 
Absence  of an  in  Vivo  Secondary  CTL  Response  to Inactivated  Virus  after 
Adoptive Transfer.  Two points  emerge  from  the  results  obtained  with  second- 
ary  stimulation  in  vitro:  (a)  inactivated  virus  is  capable  of  stimulating  a 
secondary  CTL  response  in  vitro;  (b)  the  response  is  observed  only  when  in 
vitro  stimulation  is  carried  out  with  the  homologous  virus  strain  used  in 
primary  immunization  and  the  cytotoxic  activity  is  directed  exclusively  to  the 
target  cells infected  with  the  homologous  virus  strain.  These  in  vitro  observa- 1244  INDUCTION  OF  VIRUS-SPECIFIC  CYTOTOXIC  T  CELLS 
TABLE  V 
Adoptive in Vivo Secondary  Cytotoxic Response  to Infectious  and Inactivated Influenza 
Yirlts 
Immune  Effector 
cells  Secondary  cell  to tar- 
trans-  stimulation*  get cell  ra- 
ferred*  tio§ 
% Specific ~lCr release from target cell~l 
Uninfected  A/WSN  AfJAP  B/LEE 
A/WSN  A/WSN-In-  25:1  1.5 ±  0.1  5.0  -+ 0.2  3.7  ±  0.1  4.6  ±  0.1 
activated  50:1  1.3  _  O.1  6.8  ±  0.2  4.4  +_ 0.1  4.3  _+ 0.1 
A/WSN  A/JAP-In-  25:1  1.0  2.5  ±  0.1  1.6 ±  0.1  3.9  ±  0.1 
activated  50:1  2.0  ±  0.1  5.4  +_ 0.1  3.9  ±  0.1  4.8 ±  0.3 
A/WSN  A/WSN-In-  25:1  2.5  +_ 0.1  69.4 ±  1.9  32.7  ±  1.9  4.5  ±  0.1 
fectious  50:1  3.9 ±  0.1  83.6  ±  3.1  50.4 -+ 2.9  6.8 ±  0.2 
A/WSN  None  25:1  1.7 ±  0.1  1.7  ±  0.1  2.0 _+ 0.1  2.7  ±  0.1 
50:1  2.1  ±  0.1  4.7  ±  0.1  3.8 ±  0.1  4.2  ±  0.1 
A/JAP  A/WSN-In-  25:1  3.7  _  0.1  3.5  +  0.1  6.3  -+ 0.1  6.1  -+ 0.2 
activated  50:1  4.0 ±  0.1  6.6  ±  0.4  8.1  ±  0.1  6.7  ±  0.2 
A/JAP  A/JAP-In-  25:1  4.4 ±  0,2  5.8 ±  0.2  8.1  _+ 0.2  6.5  ±  0.5 
activated  50:1  5.9 ±  0.1  6.7  ±  0.3  10.5 ±  0.5  7.1  ±  0.3 
A/JAP  A/JAP-In-  25:1  6.1  ±  0.3  45.7  _  2.0  47.2  -  0.5  8.5  ±  0.6 
fectious  50:1  8.4 ±  0.3  63.2  ±  2.6  63.5  ±  1.7  12.2  ±  0.6 
A/JAP  None  25:1  6.2  ±  0.2  5.5  ±  0.2  6.1  +  0.1  8.0  ±  0.4 
50:1  8.5 ±  0.1  10.6 ±  0.2  12.2  ±  0.1  10.3  ±  0.1 
* Spleen cells from mice previously primed with the indicated infectious virus were transferred 
into sublethally irradiated (450  rads) mice.  Recipient mice were immediately challenged with 
the indicated virus as described (Materials and Methods). Recipient spleens were examined for 
cytotoxic activity 5 days later on the indicated target cells. 
$ i.v. inoculation of 1,000 HAU of inactivated virus or 100 HAU of infectious virus. 
§ As in Table I. 
II Values are the means ±  standard errors of the mean from four wells with spontaneous release 
substracted. 
tions  prompted  a  re-examination  of  the  capacity  of  UV-inactivated  virus  to 
stimulate  in vivo secondary  CTL  responses  under  conditions  where  circulating 
anti-viral  antibody  was  eliminated.  This  situation  was  achieved  by  adoptive 
transfer  of  spleen  cells  from  mice  primed  with  infectious  A/WSN  or  A/JAP 
viruses  into  sublethally  irradiated  syngeneic  recipients.  Recipient  mice  were 
then  challenged  with  either  inactivated  A/WSN,  inactivated  A/JAP,  or  the 
infectious  homologous  virus  used  in  primary  immunization.  5  days  later,  the 
spleens  of these  recipients  were  examined  for  cytotoxic  activity  (Table  V).  In 
contrast  to the results  obtained  in vitro,  recipients  of A/JAP-primed  spleen  cells 
failed  to  respond  either  to  inactivated  A/JAP  or  A/WSN  virus.  Likewise, 
recipients  of A/WSN  primed  spleen  cells failed  to generate  cytotoxic  responses 
when  secondarily  stimulated  with  either  inactivated  virus  preparation.  On  the 
other  hand,  recipients  of virus-primed  cells,  when  inoculated  with  infectious 
homologous  virus,  generated  significant  CTL  responses.  Thus,  in the  absence  of T.  J.  BRACIALE  AND  K.  L.  YAP 
TABLE  VI 
Sensitization of Target Cells for Cell-Mediated Cytotoxicity by 
Inactivated Influenza Virus 
Target cell treatment* 
% Specific  5~Cr release  Relative virus  from treated  target 
concentrations  cells§ 
A/JAP-Inactivated  2  23.7 ± 0.3 
20  20.7 ± 1.1 
200  19.9 ± 1.0 
1245 
A/JAP-Infectious  1  86.2 -+ 0.7 
A/WSN-Inactivated  2  17.3 ± 0.3 
20  23.3 ± 0.8 
200  21.9 ± 0.7 
A/WSN-Infectious  1  97.2 ±  I.i 
B/LEE-Infectious  1  20.4 ± 0.6 
None  -  16.5 -+ 0.6 
* ~iCr-labeled P815 cells were incubated with the indicated virus prep- 
aration as described (Materials and Methods). 
* Target cells were incubated either with infectious AJWSN, A/JAP, or 
B/LEE virus at a concentration of 30 HAU per 10  e cells (10 EIDso U/ 
cell) or with  2,  20,  or 200-fold higher concentrations  of inactivated 
virus. 
§ Target cells were exposed to potent secondary cytotoxic effectors for 8 
h  at  an  effecter:target  ratio  of 5:1. Cytotoxic effectors directed  to 
influenza A/JAP were generated in vitro as described (Materials and 
Methods). 
circulating  anti-viral  antibody,  a  potent  CTL  response  can  be  obtained  on 
secondary  stimulatibn  with  homologous  infectious  virus.  However,  neither 
homologous virus nor heterologous type A  influenza virus,  when inactivated, 
stimulated a  cytotoxic response under these conditions. 
Lack of Target Cell Sensitization with Inactivated Influenza Virus.  Several 
laboratories have reported that treatment of uninfected cells with inactivated 
paramyxoviruses (12,  13) or paramyxovirus subviral components (17) rendered 
these  cells  susceptible  to  specific  lysis  by  cytotoxic T  cells  directed  to  these 
viruses.  Because  of the  disparity  between  the  in  vivo  and  in  vitro  results 
described above,  it was of interest to determine if inactivated influenza virus 
could sensitize putative target cells for lysis by influenza specific CTL in vitro. 
~lCr-labeled uninfected P815 mastocytoma cells were incubated under standard 
conditions  (see Materials  and Methods) with infectious A/WSN, A/JAP, or B/ 
LEE  viruses  or with various concentrations of UV-inactivated A/WSN or A/ 
JAP  viruses  and  exposed  in  a  standard  cytotoxicity assay  to  highly  potent 
influenza A/JAP-specific secondary effectors generated in vitro  (Table VI). As 
demonstrated previously (Table IV and [19]), target cells infected with either A/ 
WSN or A/JAP infectious virus were highly susceptible to lysis by these effector 
cells. On the other hand, target cells treated with inactivated A/WSN or A/JAP 
at concentrations up to 200-fold higher than the concentration of infectious virus 1246  INDUCTION  OF  VIRUS-SPECIFIC  CYTOTOXIC  T  CELLS 
needed to sensitize target cells, showed no lysis above background observed on 
B/LEE-infected or uninfected target cells. Identical results were obtained with 
secondary effectors specific for influenza A/WSN (not shown). The high degree 
of background  lysis demonstrable  on  influenza  B/LEE-infected  or uninfected 
target  cells has been previously observed with virus-specific cytotoxic T  cells 
generated  in vitro  (3,  8) and  was somewhat magnified by the relatively high 
effector to target ratio  (5:1) and the longer incubation time  (8 h) employed in 
the  assay.  These  assay conditions  were  chosen  to  increase  the  possibility of 
detecting sensitization of target cells by inactivated virus. 
Discussion 
In  this  report,  we have  examined  the  issue  of whether  infectious  virus  is 
necessary both for the induction of CTL responses (i.e., stimulator cell sensiti- 
zation) and for target cell sensitization or alternatively, whether induction and 
target cell sensitization can be achieved with noninfectious virus preparations. 
We have observed that while infectious influenza virus was highly efficient at 
inducing both primary and secondary influenza-specific CTL responses, nonin- 
fectious (UV-inactivated) influenza virus failed to stimulate detectable primary 
or  secondary CTL responses  in  vivo.  Similarly,  noninfectious  virus  failed to 
sensitize  target  cells for lysis by influenza-specific  cytotoxic T  cells  in  vitro. 
However, inactivated virus could stimulate an influenza-specific secondary CTL 
response in vitro. 
Before considering possible interpretations  and implications of these results, 
two critical issues pertinent to our in vivo observations must be considered. The 
first  issue  is  whether  the  inactivation  procedure  itself  rendered  the  virus 
immunologically  inactive.  This  possibility is unlikely  since inactivated  virus 
was capable of stimulating an adequate humoral immune response in vivo and 
could in vitro stimulate a  specific cell-mediated cytotoxic response.  The second 
issue  is  whether  the  parenteral  administration  of infectious  influenza  virus 
generates a sufficient antigen dose, as a  result of replication in vivo, to induce 
a CTL response, whereas noninfectious (inactivated) virus fails to achieve such 
stimulatory antigen concentrations.  We have attempted to approach this issue 
by  examining  the  antigen  dose  dependence  of  CTL  generation  with  both 
infectious  and  inactivated  virus.  Although  low  doses of infectious  influenza 
virus (10-2-10 -2 HAU) induced detectable cytotoxic T-cell responses in vivo, no 
specific  cytotoxic  activity  was  detectable  in  vivo  with  105-106-fold  higher 
concentrations  of inactivated  virus  (Fig.  1,  Table I).  Furthermore,  since the 
humoral immune response to both infectious and inactivated virus was propor- 
tional  to the immunizing  virus dose and  similar  in  magnitude,  it  is unlikely 
that extensive virus replication occurs in vivo after intravenous inoculation of 
infectious influenza  virus.  Also,  current  evidence indicates  that  the relevant 
target organs, presumably involved in the clearance of the parenterally admin- 
istered virus inoculum  (e.g.,  liver,  spleen,  lymph nodes), are not productively 
infected with influenza  virus (26,  27). Taken together,  these observations sug- 
gest that the difference between infectious and noninfectious influenza viruses 
in their respective capacities induce CTL responses in vivo is not purely a func- 
tion of antigen dose in vivo. 
A number of laboratories have recently reported results different from those T.  J.  BRACIALE  AND  K.  L.  YAP  1247 
reported here (12-15,  17).  The results  which are perhaps most germane to the 
present discussion involve the paramyxovirus model where inactivated virus 
preparations have been shown to both induce virus-specific  CTL responses (12, 
13) and sensitize  target cells  for T-cell-mediated lysis  in vitro (12,  13, 17).  The 
difference  between these observations and those reported here, we believe,  lies 
in  the  fact  that  the  paramyxovirus virion  possesses a specific  fusion protein (28) 
which allows for  the efficient  integration of  virion  surface antigens into  the cell 
cytoplasmic membrane  (28)  and also promotes cell-to-cell  fusion  (29). Such 
fusion activity  has not  been demonstrated in  influenza viruses (29,  30).  Further- 
more, it has been recently reported that a functionally active  fusion protein is 
necessary for  the sensitization  of  target cells  by a UV-inactivated paramyxovi- 
rus (31).  In the light  of  these findings and our inability  to sensitize  target cells 
with inactivated influenza viruses (Table VI), we propose that both for the 
induction of  virus-specific  CTL responses and for  the expression of  the effector 
activity  of  CTL, the  relevant viral  antigens must be presented on the surface of 
the putative stimulator or target cell  as integral membrane components, i.e., 
inserted into  the membrane  lipid  bilayer. Such a situation could be readily 
achieved either by direct integration of the virion antigens into the cell 
membrane through fusion,  as in the case of  paramyxoviruses and other  viruses 
which possess efficient  fusion capacity or as exemplified by viruses such as 
influenza,  which lack such efficient  fusion activity,  by incorporation of  nascent 
antigens into  the cell  membrane during the course of  virus infection. 
Although our results on the induction of CTL responses in vivo and target 
cell  sensitization  in vitro  with inactivated influenza virus are consistent with 
the above  hypothesis,  the  induction  of a  secondary  cytotoxic response to 
inactivated virus in vitro  is in apparent disagreement. This result  is open to 
two interpretations:  first,  it is possible  that there is a qualitative  difference  in 
the requirements for CTL induction under in vitro  conditions of stimulation, 
i.e.,  precursors of  cytotoxic  T cells  can be directly  stimulated by free  virus or 
virus adsorbed to  the stimulator cell  surface in vitro  but not in vivo. Second, it 
is possible  that this  difference  is quantitative, i.e.,  inactivated influenza virus 
is capable of  sensitizing  stimulator cells  by integration of  virion antigens into 
the cell  cytoplasmic membrane but with an efficiency  too low to be detectable 
either  at  the level  of  target cell  sensitization  in  vitro  or  under in  vivo conditions 
of stimulation. In vitro conditions of stimulation, on the other hand, would 
favor the detection of  a response to the small number of  sensitized  stimulator 
cells  generated by inactivated virus.  A resolution of  this  point may come from 
experiments with purified influenza virus antigens which have recently been 
shown to stimulate a specific  CTL response from primed cells  in vitro (32).  2 
Such studies are now in progress. 
At least  two distinct  subpopulations of cytotoxic T  cells  are generated in 
response to infectious  type A influenza virus (19,  24),  one of  which is  specific  for 
the immunizing virus strain  (virus-strain-specific),  the other of  which exhibits 
a high degree of  crossreactivity  for target cells  infected  with type A  influenza 
viruses of  any subtype (19,  24, 33).  Current evidence suggests that the target 
antigens for  these two cytotoxic  subpopulations are the  influenza virion  surface 
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glycoproteins  (hemagglutinin  and  possibly neuraminidase)  and  the  internal 
virion antigen matrix protein, respectively (34).  Since inactivated influenza A/ 
JAP  stimulated  a  cytotoxic  response  which  was  specific  for  A/JAP  targets 
(Table  IV),  only the  virus-strain-specific  CTL subpopulation  appears  to have 
been generated in response to this virus preparation. 3 This result implies that 
the in vitro response to inactivated A/JAP virus was not due to a  low level of 
infectious  virus  in  the  virion  preparation  since  infectious  A/JAP  virus  also 
stimulates a  response in the crossreactive cytotoxic subpopulation  (Table IV). 
Zweerink et al.  (32),  however, have recently reported the induction of a  CTL 
response  to  UV-inactivated  influenza  virus  which  was  highly  cross-reactive. 
The  most  likely cause for the  discrepancy  between our results  and  those of 
Zweerink et al. is the difference in the extent of virus inactivation:  7 min vs.  1 
min  UV  exposure,  respectively.  Since  the  infectivity  of an  influenza  virus 
preparation  is lost more rapidly during  inactivation  than  the capacity of the 
virions to direct the synthesis of specific viral antigens  (35), it is possible that a 
partially inactivated virus preparation,  although incapable of producing infec- 
tious virions,  is capable of directing the synthesis and expression of relevant 
viral  antigens  on  the  stimulator  cell  surface  during  an  abortive  cycle  of 
replication.  Consistent  with this  concept is the observation that  the putative 
target  antigen  for  cross-reactive  cytotoxic  subpopulation,  influenza  matrix 
protein  (34) is expressed on the cell surface during the course of infection  (34, 
36, 37) but is internally located in the influenza virion (30). Two other reports of 
CTL responses  to  inactivated  virus  (14,  15)  might  be explained  on  a  similar 
basis, i.e., synthesis and expression of the relevant viral antigens in the absence 
of infectious virus production. Since, in these reports, the capacity of inactivated 
virus to sensitize target cells or to direct nascent viral protein synthesis was not 
examined, the discrepancy between these observations and those reported here, 
remains to be resolved. 
An  observation  reported  here  which  warrants  further  discussion  is  the 
capacity of inactivated influenza virus to stimulate an in vivo primary humoral 
immune response in the absence of a detectable CTL response in vivo. Since the 
induction  of an  in vivo primary humoral immune response to influenza virus 
has been shown to be thymus-dependent  (38-40), it is likely that helper T cells 
can  be  activated  by either  infectious  or  inactivated  influenza  virus  in  vivo. 
However, only infectious virus stimulates  a  detectable CTL response in vivo. 
One  possible  interpretation  of this  observation  is  that  helper  T  cells  and 
cytotoxic  T-cell  precursors  differ  in  their  requirements  for  induction  with 
respect to mode of antigen  presentation.  According to the hypothesis outlined 
above, the induction of a  CTL response to specific viral antigens would require 
their  presentation  on the  stimulator  cell  as integral  membrane  components, 
whereas  the  activation  of helper  T  cells  directed to these  antigens  could be 
achieved in a  manner analogous to that suggested for soluble antigens  (41). In 
this  connection,  it  should  be  noted  that  precursors  of helper  T  cells  and 
precursors  of cytotoxic T  cells  also differ in  their  requirements  for induction 
By using appropriate recombinant influenza virus strains, the specificity of the cytotoxic cells 
for influenza A/JAP hemagglutinin has been demonstrated (T. J. Braciale, unpublished observa- 
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with respect to genes in the MHC (42-44). The question of whether this genetic 
difference  in  the  requirement  for  helper  and  cytotoxic T-cell  induction  is  a 
reflection  of the  difference  in  the  mode of antigen  presentation  will require 
further analysis of these two T-cell subsets. 
The requirement  for viral infectivity in the induction  of virus-specific cyto- 
toxic T cells remains to be fully elucidated.  Factors which should be considered 
in  assessing  this  requirement  include:  (a)  whether  the  virus  employed has 
efficient  fusion  activity  which  could  promote  efficient  integration  of virion 
antigens into the cell cytoplasmic membrane; (b) whether an inactivated virus 
preparation which fails to undergo a complete cycle of replication, i.e., produce 
infectious virus,  is also incapable  of inducing  nascent  viral  protein  synthesis 
during an abortive cycle of replication;  (c) whether the analysis is undertaken 
in vivo or in vitro. Based on our own observations and those of other investiga- 
tors we have proposed that both the induction of virus-specific cytotoxic T cells 
and  the  expression  of their  lytic  activity  requires  the  presentation  of the 
relevant viral antigens on the surface of the stimulator or target cell as integral 
membrane components. Experiments are now in progress to test this proposal. 
Summary 
This report examines the requirement for infectious virus in the induction of 
influenza virus-specific cytotoxic T cells. Infectious influenza virus was found to 
be highly  efficient at generating  both primary  and secondary cytotoxic T-cell 
response  in  vivo.  Inactivated  influenza  virus  however,  failed to  stimulate  a 
detectable cytotoxic T-cell response in vivo even at immunizing  doses 105-10  e- 
fold higher  than  the minimum  stimulatory  dose of infectious virus.  Likewise 
inactivated virus failed to sensitize target cells for T-cell-mediated lysis in vitro 
but  could stimulate  a  specific cytotoxic response  from  primed  cells  in  vitro. 
Possible  requirements  for  the  induction  of virus-specific  cytotoxic T-cell  re- 
sponses are discussed in light of these observations and those of other investi- 
gators. 
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